Found: 2
Select item for more details and to access through your institution.
Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.
- Published in:
- Scientific Reports, 2017, p. 45954, doi. 10.1038/srep45954
- By:
- Publication type:
- Article
Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells.
- Published in:
- Scientific Reports, 2017, p. 44075, doi. 10.1038/srep44075
- By:
- Publication type:
- Article